Human Biliary Glycoprotein Gene: Characterization of a Family of Novel Alternatively Spliced RNAs and Their Expressed Proteins
Overview
Authors
Affiliations
Eight different human biliary glycoprotein (BGP) isoantigens, structurally related members of the carcinoembryonic antigen family, CD66/67 family, and immunoglobulin superfamily, are derived by alternative splicing from a single genomic transcription unit. Novel BGP isoforms have been identified by polymerase chain reaction amplification and by DNA sequencing of amplified cDNA segments. In addition to verifying previously documented BGPs, we describe four new forms, two of which have unusual nonimmunoglobulin exons contributed by inverted Alu repeats. Determination of the genomic DNA sequence encompassing most of the known extracellular and intracellular domains demonstrates that the translatable Alu-like sequences are encoded in bona fide exons. The third novel BGP isoform contains none of the extracellular disulfide-linked immunoglobulin-like domains typical of these molecules but retains N-terminal and intracellular domains, suggesting distinct functions for N-terminal versus other disulfide-linked domains. cDNAs coding for each identified isoform have been transfected into COS7 monkey cells, and the resulting polypeptides are heavily N glycosylated but can be deglycosylated to their expected primary sizes. Many of these deglycosylated forms can be correlated with unique patterns of BGP expression in different cell lines, while in granulocytes, some previously undescribed or alternatively modified forms may predominate. The BGP family represents a potentially large but unknown source of functional diversity among cells of epithelial and hematopoietic origin. The availability of a defined set of expressed of BGP cDNAs should permit critical definition of their function.
Mechanism and function of CEACAM1 splice isoforms.
Dery K, Najjar S, Beauchemin N, Shively J, Kupiec-Weglinski J Eur J Clin Invest. 2024; 54 Suppl 2:e14350.
PMID: 39674874 PMC: 11646291. DOI: 10.1111/eci.14350.
Targeted splicing therapy: new strategies for colorectal cancer.
Zheng Y, Zhong G, He C, Li M Front Oncol. 2023; 13:1222932.
PMID: 37664052 PMC: 10470845. DOI: 10.3389/fonc.2023.1222932.
Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape.
Navarro E, Mallen A, Hueso M Biomedicines. 2021; 9(11).
PMID: 34829789 PMC: 8615635. DOI: 10.3390/biomedicines9111560.
CEACAM1 in Liver Injury, Metabolic and Immune Regulation.
Horst A, Najjar S, Wagener C, Tiegs G Int J Mol Sci. 2018; 19(10).
PMID: 30314283 PMC: 6213298. DOI: 10.3390/ijms19103110.
Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Oliveira-Ferrer L, Goswami R, Galatenko V, Ding Y, Eylmann K, Legler K Dis Markers. 2018; 2018:6714287.
PMID: 30050594 PMC: 6046165. DOI: 10.1155/2018/6714287.